Flamen P - Search Results

1

Fat density is a novel prognostic marker in patients with esophageal cancer.

Anciaux M, Van Gossum A, Wenglinski C, Ameye L, Guiot T, Flamen P, Demetter P, Deleporte A, Sclafani F, Donckier V, Hendlisz A, Vandeputte C. Anciaux M, et al. Among authors: flamen p. Clin Nutr ESPEN. 2020 Oct;39:124-130. doi: 10.1016/j.clnesp.2020.07.007. Epub 2020 Aug 11. Clin Nutr ESPEN. 2020. PMID: 32859305

2

Positron emission tomography in colorectal cancer.

Flamen P. Flamen P. Best Pract Res Clin Gastroenterol. 2002 Apr;16(2):237-51. doi: 10.1053/bega.2001.0283. Best Pract Res Clin Gastroenterol. 2002. PMID: 11969236 Review.

3

Positron emission tomography in gastric and esophageal cancer.

Flamen P. Flamen P. Curr Opin Oncol. 2004 Jul;16(4):359-63. doi: 10.1097/01.cco.0000128276.13585.fa. Curr Opin Oncol. 2004. PMID: 15187891 Review.

4

Inducing resectability of chemotherapy refractory colorectal liver metastasis by radioembolization with yttrium-90 microspheres.

Van den Eynde M, Flamen P, El Nakadi I, Liberale G, Delatte P, Larsimont D, Hendlisz A. Van den Eynde M, et al. Among authors: flamen p. Clin Nucl Med. 2008 Oct;33(10):697-9. doi: 10.1097/RLU.0b013e318184b9a0. Clin Nucl Med. 2008. PMID: 18806572 No abstract available.

5

Multimodality imaging can predict the metabolic response of unresectable colorectal liver metastases to radioembolization therapy with Yttrium-90 labeled resin microspheres.

Flamen P, Vanderlinden B, Delatte P, Ghanem G, Ameye L, Van Den Eynde M, Hendlisz A. Flamen P, et al. Phys Med Biol. 2008 Nov 21;53(22):6591-603. doi: 10.1088/0031-9155/53/22/019. Epub 2008 Oct 31. Phys Med Biol. 2008. PMID: 18978442

6

Progressive osteoblastic bone metastases in breast cancer negative on FDG-PET.

Huyge V, Garcia C, Vanderstappen A, Alexiou J, Gil T, Flamen P. Huyge V, et al. Among authors: flamen p. Clin Nucl Med. 2009 Jul;34(7):417-20. doi: 10.1097/RLU.0b013e3181a7d03c. Clin Nucl Med. 2009. PMID: 19542943

7

State of the art: radiolabeled microspheres treatment for liver malignancies.

Deleporte A, Flamen P, Hendlisz A. Deleporte A, et al. Among authors: flamen p. Expert Opin Pharmacother. 2010 Mar;11(4):579-86. doi: 10.1517/14656560903520916. Expert Opin Pharmacother. 2010. PMID: 20163269 Review.

8

Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy.

Hendlisz A, Van den Eynde M, Peeters M, Maleux G, Lambert B, Vannoote J, De Keukeleire K, Verslype C, Defreyne L, Van Cutsem E, Delatte P, Delaunoit T, Personeni N, Paesmans M, Van Laethem JL, Flamen P. Hendlisz A, et al. Among authors: flamen p. J Clin Oncol. 2010 Aug 10;28(23):3687-94. doi: 10.1200/JCO.2010.28.5643. Epub 2010 Jun 21. J Clin Oncol. 2010. PMID: 20567019 Clinical Trial.

9

Detection and characterization of tumor changes in 18F-FDG PET patient monitoring using parametric imaging.

Necib H, Garcia C, Wagner A, Vanderlinden B, Emonts P, Hendlisz A, Flamen P, Buvat I. Necib H, et al. Among authors: flamen p. J Nucl Med. 2011 Mar;52(3):354-61. doi: 10.2967/jnumed.110.080150. J Nucl Med. 2011. PMID: 21345787 Free article.

10

Lesion-based detection of early chemosensitivity using serial static FDG PET/CT in metastatic colorectal cancer.

Buvat I, Necib H, Garcia C, Wagner A, Vanderlinden B, Emonts P, Hendlisz A, Flamen P. Buvat I, et al. Among authors: flamen p. Eur J Nucl Med Mol Imaging. 2012 Oct;39(10):1628-34. doi: 10.1007/s00259-012-2172-2. Epub 2012 Jun 19. Eur J Nucl Med Mol Imaging. 2012. PMID: 22710958 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

178 results

Search Page

Filters